Abstracts Archive - Page 210 of 1683 - ATC Abstracts

2021 American Transplant Congress
The Quality Incentive Program (QIP) is Associated with Increased Waitlisting for Transplantation
J. T. Adler¹, L. Xiang¹, J. S. Weissman¹, J. R. Rodrigue², R. E. Patzer³, S. S. Waikar⁴, T. C. Tsai¹
¹Surgery, Brigham and Women's Hospital, Boston, MA, ²Surgery, Beth Israel Deaconess Medical Center, Boston, MA, ³Surgery, Emory University, Atlanta, GA, ⁴Surgery, Boston Medical Center, Boston, MA
*Purpose: The Centers for Medicare & Medicaid Services (CMS) introduced the Quality Incentive Program (QIP) in 2012, a pay-for-performance program which penalizes dialysis centers payments…
2021 American Transplant Congress
Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience
S. Dionne, B. O'Neale
VRL-Eurofins, Centennial, CO
*Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…
2021 American Transplant Congress
Impact of Covid-19 Infection on Tacrolimus Levels in Solid Organ Transplant Recipients
K. Heagler, K. Tejani, S. Sanchez
Loyola University Medical Center, Maywood, IL
*Purpose: Immunocompromised patients are considered to be at high-risk for infection with SARS-CoV-2 (COVID-19). There have been observations within the transplant community that patients infected…
2021 American Transplant Congress
Influence of Vitamin D Status on the Prognosis of Covid 19 in Patients with Kidney Transplant
J. Ugalde-Altamirano, I. Revuelta, A. Carrillo, M. Xipell, F. Cofan, N. Esforzado, E. Montagud, G. Piñeiro, A. Molina, P. Ventura, D. Cucchiari, F. Oppenheimer, F. Diekmann, J. Campistol, B. Bayes, J. Torregrosa
Nephrology, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: The protective role of Vitamin D as an immunomodulator has been demonstrated in different pathologies included the viral etiology. This effect has been described…
2021 American Transplant Congress
Impact of Electronic Donor Referral Technology on Deceased Donor Referrals
B. Boyarsky¹, J. R. DiRito², K. Vanterpool¹, J. Piano³, W. Liu³, J. Hewlett⁴, C. Trahan⁴, D. Segev¹, M. Levan¹, A. Massie¹, P. Niles⁴
¹Johns Hopkins, Baltimore, MD, ²Yale, New Haven, CT, ³Transplant Connect, Santa Monica, CA, ⁴Southwest Transplant Alliance, Dallas, TX
*Purpose: Hospitals likely fail to refer many medically eligible potential deceased donors to OPOs. As such, increasing eligible referrals may increase the donor pool. We…
2021 American Transplant Congress
The Use of Organs from Donors That Do Not Meet Eligibility Criteria in the United States
L. Deroos, M. Lavieri, D. Hutton, W. Marrero, N. Parikh
University of Michigan, Ann Arbor, MI
*Purpose: Increasing the number of organs available for transplantation could reduce waitlist morbidity and mortality for patients with end organ failure. Most transplanted organs come…
2021 American Transplant Congress
Elevated Tacrolimus Levels in Hospitalized Organ Transplant Recipients with COVID-19
K. Mecadon¹, A. Hardesty², K. Vieira³, R. Rogers³, B. Merhi⁴, A. J. Osband⁵, G. Bayliss⁴, R. Gohh⁴, P. Morrissey⁵, D. Farmakiotis³
¹Department of Pharmacy, Rhode Island Hospital, Providence, RI, ²Department of Internal Medicine, Residency, Warren Alpert Medical School of Brown University, Providence, RI, ³Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, ⁴Division of Nephrology, Warren Alpert Medical School of Brown University, Providence, RI, ⁵Department of Surgery (Transplantation), Warren Alpert Medical School of Brown University, Providence, RI
*Purpose: The effect of COVID-19 on immunosuppressant drug levels in organ transplant recipients (OTRs) has not been adequately studied.*Methods: We retrospectively studied hospitalized adult (>18-year-old)…
2021 American Transplant Congress
The Calculated Panel of Incompatible Epitopes (cPIE) in the Service of Equitable Access to Transplantation
J. Lamsatfi¹, B. Bingfan Liu¹, S. Parto², A. Lewin³, K. Oualkacha¹, F. Claas⁴, P. Keown⁵, R. Sapir-Pichhadze⁶
¹McGill University, Montreal, QC, Canada, ²McGill University Health Centre, Montreal, QC, Canada, ³Hema-Quebec, Montreal, QC, Canada, ⁴Leiden University Medical Centre, Albinusdreef, Netherlands, ⁵University of British Columbia, Vancouver, BC, Canada, ⁶Medicine, McGill University Health Centre, Montreal, QC, Canada
*Purpose: To inform on feasibility of eplet matching, we developed the calculated Panel of Incompatible Epitopes (cPIE), an algorithm informing on the likelihood of identifying…
2021 American Transplant Congress
Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience
J. Ferrer-Fàbrega¹, R. Muñoz², J. Ruiz³, D. Casanova⁴, F. Sánchez-Bueno⁵, J. Pérez-Daga⁶, C. Fernández-Rivera⁷, M. Gómez⁸, F. Castillo⁹, R. López-Andújar¹⁰, J. Maupoey¹⁰, J. Briceño¹¹, J. Sánchez-Hidalgo¹¹, Á. Arjona¹¹, A. Álvarez¹², A. Alarcó¹³, A. Bravo¹³, R. García¹, R. Rull¹, M. López-Boado¹, P. Ventura-Aguiar¹⁴, F. Diekmann¹⁴, D. Paredes¹⁵, J. García-Valdecasas¹, J. Fuster¹, C. Fondevila¹, B. Domínguez-Gil²
¹Hepatobiliopancreatic Surgery and Transplantation Department, Hospital Clínic Barcelona, Barcelona, Spain, ²Organización Nacional de Trasplantes (ONT), Madrid, Spain, ³Department of Nephrology., University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ⁴Department of Surgery, University Hospital Marques de Valdecilla, University Cantabria, Santander., Santander, Spain, ⁵Department of General, Visceral and Transplantation Surgery., Clinic and University Hospital Virgen de la Arrixaca. IMIB-ARRIXACA. Murcia., Murcia, Spain, ⁶Department of Surgery, Hospital Regional de Málaga. Málaga., Málaga, Spain, ⁷Department of Nephrology., Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁸Department of Surgery, Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁹Department of Surgery, University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ¹⁰Hepato-Pancreatico-Biliary Surgery and Transplant Unit, La Fe University Hospital. Valencia, Valencia, Spain, ¹¹Department of Surgery, Hospital Universitario Reina Sofía. Córdoba, Córdoba, Spain, ¹²Department of Nephrology., Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹³Department of Surgery, Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹⁴Renal Transplant Unit, Hospital Clínic Barcelona, Barcelona, Spain, ¹⁵Coordination Department, Hospital Clínic Barcelona, Barcelona, Spain
*Purpose: To report on the Spanish Pancreas Transplantation experience in controlled donation after circulatory death (cDCD) by analyzing the normothermic regional perfusion (NRP) and super-rapid…
2021 American Transplant Congress
Dual Liver and Kidney Donors, What Makes Them Decide to Do It?
H. Al Harakeh, B. Emmanuel, C. Hughes, A. Tevar, J. Steel, A. F. DiMartini, S. Ganesh, A. Humar
Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: There is incongruity between the transplant waiting list and the number of deceased donors available, therefore there is an enduring challenge to increase the…